Aurinia Pharmaceuticals Inc (AUPH)
R&D Expense Growth
74.70%
Quarterly · Period ending:
AUPH R&D Expense Growth
Latest reported74.70%period ending
Latest reported74.70%period ending
AUPH Quarterly R&D Growth (QoQ) (0.00% → 74.70%)
Latest values, visible window
High-resolution chart · PNG
AUPH r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -13.3622% | |
| 71.4584% | |
| -5.108% | |
| 149.0275% | |
| -62.6704% | |
| 743.7958% | |
| -159.1947% | |
| 0% | |
| 0% |